News APP

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

This article was first published 17 years ago
Rediff.com  » Business » Panacea gets WHO accreditation for Hep-B vaccine

Panacea gets WHO accreditation for Hep-B vaccine

Source: PTI
August 02, 2006 14:34 IST
Get Rediff News in your Inbox:

Panacea Biotec Ltd said on Wednesday it has received pre-qualification accreditation from the World Health Organisation for the supply of recombinant Hepatitis B vaccine to UN agencies.

Hepatitis B immunisation strategies help to prevent chronic Hepatitis-B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer, the company informed the Bombay Stock Exchange.

The overall estimated market for Hepatitis-B vaccine and its combinations as per UNICEF and PAHO for year 2007 is around 158 million doses, which is estimated to go up to 185 million doses in 2008 and 888 million doses in 2009.

In terms of revenues, it would amount to about $270 million in 2007, going up to $390 million in 2008 and $1 billion in 2009, it said.

"There has been constant growth in Panacea Biotec revenue due to strong vaccine sales and our inclusion in the list of pre-qualified suppliers of WHO will significantly enhance our presence in this segment, resulting in better sales volumes and profitability," Panacea Biotech Joint Managing Director Rajesh Jain said.

The company's shares were trading at Rs 335, up 1.55 per cent at the BSE.

Do you want to discuss stock tips? Do you know a hot one? Join the Stock Market Investments Discussion Group

Get Rediff News in your Inbox:
Source: PTI© Copyright 2024 PTI. All rights reserved. Republication or redistribution of PTI content, including by framing or similar means, is expressly prohibited without the prior written consent.
 

Moneywiz Live!